CytomX Therapeutics, Inc. (CTMX)
5.51
+0.08
(+1.47%)
USD |
NASDAQ |
Feb 23, 10:48
CytomX Therapeutics Market Cap : 933.59M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 409.54M |
| ACADIA Pharmaceuticals, Inc. | 4.123B |
| Alnylam Pharmaceuticals, Inc. | 44.11B |
| Savara, Inc. | 1.141B |
| BioMarin Pharmaceutical, Inc. | 12.42B |
Market Cap Related Metrics
| PE Ratio | 13.18 |
| PS Ratio | 5.592 |
| PEG Ratio | 0.0899 |
| Price to Book Value | 8.694 |
| Price | 5.51 |
| Earnings Yield | 7.59% |
| PEGY Ratio | 0.0899 |
| Operating PE Ratio | 27.46 |
| Normalized PE Ratio | 13.19 |